← Home

From concept to protocol

Designing a remote oncology monitoring pilot

A pilot should answer a narrow question: can specific data and a defined review pathway operate reliably in a stated population? It should not present a feasibility study as an established medical service.

Audience
For sponsors, research sites, oncologists, IT and security teams
Status
Research information, not medical advice
Editorial
NPO NT project team; scientific concept by Dr Artem Poltoratskiy
Review
No independent external medical review of this edition is claimed
Updated
Reviewed 19 August 2026
01

Define before designing the interface

  • Population, treatment and observation period.
  • Clinical question and rationale for every measure.
  • Device, ePRO instrument and minimum dataset.
  • Threshold, priority, response hours and pathway owner.
  • Endpoints, analysis plan and stopping criteria.
02

Separate validation levels

Technical validation asks whether data transfer correctly. Analytical validation asks whether the feature is reliable. Clinical validation asks whether it relates to a state or outcome and improves a pathway. Passing one level does not prove the next.

03

Participant and data protection

Before real collection, the project needs ethics and regulatory review, a threat model, contractual roles, informed consent, a lawful basis for health data and an incident-response plan. The public site remains informational only.

Sources and traceability

Evidence used for this page

External sources remain responsible for their content. This page does not replace clinical guidance, legal advice or device-specific validation.